News from Aug 11, 2016
The Graduate Research Training Program PharMetrX: Pharmacometrics & Computational Disease Modelling is a joint initiative in Germany between the Freie Universität Berlin and the Universität Potsdam, bridging pharmacy and mathematics, supported by the research-driven pharmaceutical companies AbbVie Deutschland GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, F. Hoffmann-La Roche Ltd, Grünenthal GmbH, Merck KGaA and SANOFI.
It offers its graduate students a unique opportunity to experience research in the area of drug development and optimising drug therapy jointly within academia and industry.
The interdisciplinary PhD program is designed as a 3.5 year research program including a structured research training curriculum of advanced academic & industrial modules. PharMetrX is open to candidates with a university degree in pharmacy, mathematics/statistics, natural sciences or medicine.